G1 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	32.47	94.91	221.56	207.81	269.71	369.29	103.81	47.31	22.94
Short-Term Investments	49.94	50.48	0	0	0	0	0	0	0
Cash & Cash Equivalents	82.41	145.38	221.56	207.81	269.71	369.29	103.81	47.31	22.94
Cash Growth	-43.32%	-34.38%	6.62%	-22.95%	-26.97%	255.73%	119.45%	106.23%	-
Receivables	12.69	11.09	5.69	0.24	0	0	0	0	0
Inventory	12.44	16.18	3.47	0	0	0	0	0	0
Other Current Assets	7.41	6.84	12.85	8.35	1.3	0.84	0.85	0.6	0.81
Total Current Assets	114.95	179.5	243.57	216.39	271	370.13	104.66	47.9	23.75
Property, Plant & Equipment	6.38	7.95	9.05	10.51	13.39	1.14	0.51	0.31	0.15
Other Long-Term Assets	0.21	0.51	1.48	1.65	0.44	0	0	0	0
Total Long-Term Assets	6.59	8.47	10.53	12.16	13.83	1.14	0.51	0.31	0.15
Total Assets	121.54	187.97	254.09	228.55	284.83	371.27	105.17	48.21	23.9
Accounts Payable	3.99	7.43	2.9	3.57	3.68	3.38	4.18	2.61	1.13
Deferred Revenue	1.12	1.01	1.03	0.24	0	0	0	0	0
Other Current Liabilities	24.6	27.15	23.69	19.63	16.09	8.99	7.52	3.02	1.04
Total Current Liabilities	29.72	35.59	27.61	23.44	19.77	12.36	11.7	5.63	2.17
Long-Term Debt	55.9	82.63	81.94	27.76	9.54	0	0	0	0
Other Long-Term Liabilities	0.54	1	1	0	0	0.09	0.08	0	53.42
Total Long-Term Liabilities	56.44	83.63	82.94	27.76	9.54	0.09	0.08	0	53.42
Total Liabilities	86.15	119.22	110.55	51.2	29.3	12.45	11.78	5.63	55.59
Total Debt	55.9	82.63	81.94	27.76	9.54	0	0	0	0
Debt Growth	-32.35%	0.84%	195.19%	191.12%	-	-	-	-	-
Retained Earnings	-779.99	-732.02	-584.46	-436.11	-336.85	-214.41	-129.12	-64.99	-31.69
Shareholders' Equity	35.39	68.75	143.54	177.35	255.53	358.82	93.39	-64.99	-31.69
Net Cash / Debt	26.51	62.75	139.62	180.05	260.17	369.29	103.81	47.31	22.94
Net Cash / Debt Growth	-57.76%	-55.05%	-22.45%	-30.80%	-29.55%	255.73%	119.45%	106.23%	-
Net Cash Per Share	0.51	1.44	3.33	4.75	6.94	11.08	5.70	31.81	17.06
Working Capital	85.23	143.91	215.95	192.95	251.23	357.77	92.96	42.28	21.58
Book Value Per Share	0.68	1.58	3.42	4.68	6.81	10.77	5.13	-43.71	-23.57

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).